PUBLISHER: QYResearch | PRODUCT CODE: 1764400
PUBLISHER: QYResearch | PRODUCT CODE: 1764400
This research report focuses on the Small Molecule CMO and CDMO Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
Table 1. Global Small Molecule CMO and CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Molecular Drug Intermediates
Table 3. Key Players of API
Table 4. Key Players of Prepared Products
Table 5. Global Small Molecule CMO and CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Small Molecule CMO and CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Market Size by Region (2020-2031) & (US$ Million)
Table 8. Global Small Molecule CMO and CDMO Market Share by Region (2020-2031)
Table 9. Market Trends
Table 10. Market Drivers
Table 11. Market Challenges
Table 12. Market Restraints
Table 13. Global Small Molecule CMO and CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 14. Global Small Molecule CMO and CDMO Market Share by Players (2020-2025)
Table 15. Global Top Small Molecule CMO and CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CMO and CDMO as of 2024)
Table 16. Global Small Molecule CMO and CDMO Industry Ranking 2023 VS 2024
Table 17. Global 5 Largest Players Market Share by Small Molecule CMO and CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 18. Global Key Players of Small Molecule CMO and CDMO, Headquarters and Area Served
Table 19. Global Key Players of Small Molecule CMO and CDMO, Product and Application
Table 20. Global Key Players of Small Molecule CMO and CDMO, Date of Enter into This Industry
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Market Size by Type (2020-2025) & (US$ Million)
Table 23. Global Small Molecule CMO and CDMO Revenue Market Share by Type (2020-2025)
Table 24. Global Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 25. Global Small Molecule CMO and CDMO Revenue Market Share by Type (2026-2031)
Table 26. Global Market Size by Application (2020-2025) & (US$ Million)
Table 27. Global Small Molecule CMO and CDMO Revenue Market Share by Application (2020-2025)
Table 28. Global Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 29. Global Small Molecule CMO and CDMO Revenue Market Share by Application (2026-2031)
Table 30. North America Market Size by Type (2020-2031) & (US$ Million)
Table 31. North America Market Size by Application (2020-2031) & (US$ Million)
Table 32. North America Small Molecule CMO and CDMO Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Market Size by Country (2020-2031) & (US$ Million)
Table 34. Europe Market Size by Type (2020-2031) & (US$ Million)
Table 35. Europe Market Size by Application (2020-2031) & (US$ Million)
Table 36. Europe Small Molecule CMO and CDMO Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Market Size by Country (2020-2025) & (US$ Million)
Table 38. China Market Size by Type (2020-2031) & (US$ Million)
Table 39. China Market Size by Application (2020-2031) & (US$ Million)
Table 40. Asia Market Size by Type (2020-2031) & (US$ Million)
Table 41. Asia Market Size by Application (2020-2025) & (US$ Million)
Table 42. Asia Small Molecule CMO and CDMO Growth Rate (CAGR) by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia Market Size by Region (2020-2031) & (US$ Million)
Table 44. Middle East, Africa, and Latin America Market Size by Type (2020-2031) & (US$ Million)
Table 45. Middle East, Africa, and Latin America Market Size by Application (2020-2031) & (US$ Million)
Table 46. Middle East, Africa, and Latin America Small Molecule CMO and CDMO Growth Rate (CAGR) by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East, Africa, and Latin America Market Size by Country (2020-2031) & (US$ Million)
Table 48. Catalent Company Details
Table 49. Catalent Business Overview
Table 50. Catalent Small Molecule CMO and CDMO Product
Table 51. Catalent Revenue (2020-2025) & (US$ Million)
Table 52. Catalent Recent Development
Table 53. Thermo Fisher Scientific Company Details
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Small Molecule CMO and CDMO Product
Table 56. Thermo Fisher Scientific Revenue (2020-2025) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. Lonza Company Details
Table 59. Lonza Business Overview
Table 60. Lonza Small Molecule CMO and CDMO Product
Table 61. Lonza Revenue (2020-2025) & (US$ Million)
Table 62. Lonza Recent Development
Table 63. Siegfried Company Details
Table 64. Siegfried Business Overview
Table 65. Siegfried Small Molecule CMO and CDMO Product
Table 66. Siegfried Revenue (2020-2025) & (US$ Million)
Table 67. Siegfried Recent Development
Table 68. Recipharm Company Details
Table 69. Recipharm Business Overview
Table 70. Recipharm Small Molecule CMO and CDMO Product
Table 71. Recipharm Revenue (2020-2025) & (US$ Million)
Table 72. Recipharm Recent Development
Table 73. Boehringer Ingelheim Company Details
Table 74. Boehringer Ingelheim Business Overview
Table 75. Boehringer Ingelheim Small Molecule CMO and CDMO Product
Table 76. Boehringer Ingelheim Revenue (2020-2025) & (US$ Million)
Table 77. Boehringer Ingelheim Recent Development
Table 78. WuXi AppTech Company Details
Table 79. WuXi AppTech Business Overview
Table 80. WuXi AppTech Small Molecule CMO and CDMO Product
Table 81. WuXi AppTech Revenue (2020-2025) & (US$ Million)
Table 82. WuXi AppTech Recent Development
Table 83. WuXi Biologics Company Details
Table 84. WuXi Biologics Business Overview
Table 85. WuXi Biologics Small Molecule CMO and CDMO Product
Table 86. WuXi Biologics Revenue (2020-2025) & (US$ Million)
Table 87. WuXi Biologics Recent Development
Table 88. Fareva Company Details
Table 89. Fareva Business Overview
Table 90. Fareva Small Molecule CMO and CDMO Product
Table 91. Fareva Revenue (2020-2025) & (US$ Million)
Table 92. Fareva Recent Development
Table 93. Samsung Biologics Company Details
Table 94. Samsung Biologics Business Overview
Table 95. Samsung Biologics Small Molecule CMO and CDMO Product
Table 96. Samsung Biologics Revenue (2020-2025) & (US$ Million)
Table 97. Samsung Biologics Recent Development
Table 98. Aenova Company Details
Table 99. Aenova Business Overview
Table 100. Aenova Small Molecule CMO and CDMO Product
Table 101. Aenova Revenue (2020-2025) & (US$ Million)
Table 102. Aenova Recent Development
Table 103. Delpharm Company Details
Table 104. Delpharm Business Overview
Table 105. Delpharm Small Molecule CMO and CDMO Product
Table 106. Delpharm Revenue (2020-2025) & (US$ Million)
Table 107. Delpharm Recent Development
Table 108. Strides Pharma Company Details
Table 109. Strides Pharma Business Overview
Table 110. Strides Pharma Small Molecule CMO and CDMO Product
Table 111. Strides Pharma Revenue (2020-2025) & (US$ Million)
Table 112. Strides Pharma Recent Development
Table 113. Piramal Company Details
Table 114. Piramal Business Overview
Table 115. Piramal Small Molecule CMO and CDMO Product
Table 116. Piramal Revenue (2020-2025) & (US$ Million)
Table 117. Piramal Recent Development
Table 118. Famar Company Details
Table 119. Famar Business Overview
Table 120. Famar Small Molecule CMO and CDMO Product
Table 121. Famar Revenue (2020-2025) & (US$ Million)
Table 122. Famar Recent Development
Table 123. Curia Company Details
Table 124. Curia Business Overview
Table 125. Curia Small Molecule CMO and CDMO Product
Table 126. Curia Revenue (2020-2025) & (US$ Million)
Table 127. Curia Recent Development
Table 128. Jubilant Company Details
Table 129. Jubilant Business Overview
Table 130. Jubilant Small Molecule CMO and CDMO Product
Table 131. Jubilant Revenue (2020-2025) & (US$ Million)
Table 132. Jubilant Recent Development
Table 133. Vetter Company Details
Table 134. Vetter Business Overview
Table 135. Vetter Small Molecule CMO and CDMO Product
Table 136. Vetter Revenue (2020-2025) & (US$ Million)
Table 137. Vetter Recent Development
Table 138. AGC Pharma Chemicals Company Details
Table 139. AGC Pharma Chemicals Business Overview
Table 140. AGC Pharma Chemicals Small Molecule CMO and CDMO Product
Table 141. AGC Pharma Chemicals Revenue (2020-2025) & (US$ Million)
Table 142. AGC Pharma Chemicals Recent Development
Table 143. Asymchem Company Details
Table 144. Asymchem Business Overview
Table 145. Asymchem Small Molecule CMO and CDMO Product
Table 146. Asymchem Revenue (2020-2025) & (US$ Million)
Table 147. Asymchem Recent Development
Table 148. Porton Company Details
Table 149. Porton Business Overview
Table 150. Porton Small Molecule CMO and CDMO Product
Table 151. Porton Revenue (2020-2025) & (US$ Million)
Table 152. Porton Recent Development
Table 153. Eurofins Company Details
Table 154. Eurofins Business Overview
Table 155. Eurofins Small Molecule CMO and CDMO Product
Table 156. Eurofins Revenue (2020-2025) & (US$ Million)
Table 157. Eurofins Recent Development
Table 158. Ascendia Pharmaceuticals Company Details
Table 159. Ascendia Pharmaceuticals Business Overview
Table 160. Ascendia Pharmaceuticals Small Molecule CMO and CDMO Product
Table 161. Ascendia Pharmaceuticals Revenue (2020-2025) & (US$ Million)
Table 162. Ascendia Pharmaceuticals Recent Development
Table 163. Ardena Company Details
Table 164. Ardena Business Overview
Table 165. Ardena Small Molecule CMO and CDMO Product
Table 166. Ardena Revenue (2020-2025) & (US$ Million)
Table 167. Ardena Recent Development
Table 168. CPL Company Details
Table 169. CPL Business Overview
Table 170. CPL Small Molecule CMO and CDMO Product
Table 171. CPL Revenue (2020-2025) & (US$ Million)
Table 172. CPL Recent Development
Table 173. UPM Pharmaceuticals Company Details
Table 174. UPM Pharmaceuticals Business Overview
Table 175. UPM Pharmaceuticals Small Molecule CMO and CDMO Product
Table 176. UPM Pharmaceuticals Revenue (2020-2025) & (US$ Million)
Table 177. UPM Pharmaceuticals Recent Development
Table 178. FUJIFILM Diosynth Biotechnologies Company Details
Table 179. FUJIFILM Diosynth Biotechnologies Business Overview
Table 180. FUJIFILM Diosynth Biotechnologies Small Molecule CMO and CDMO Product
Table 181. FUJIFILM Diosynth Biotechnologies Revenue (2020-2025) & (US$ Million)
Table 182. FUJIFILM Diosynth Biotechnologies Recent Development
Table 183. Groupe Parima Company Details
Table 184. Groupe Parima Business Overview
Table 185. Groupe Parima Small Molecule CMO and CDMO Product
Table 186. Groupe Parima Revenue (2020-2025) & (US$ Million)
Table 187. Groupe Parima Recent Development
Table 188. TBD Pharmatech Company Details
Table 189. TBD Pharmatech Business Overview
Table 190. TBD Pharmatech Small Molecule CMO and CDMO Product
Table 191. TBD Pharmatech Revenue (2020-2025) & (US$ Million)
Table 192. TBD Pharmatech Recent Development
Table 193. Avid Bioservices Company Details
Table 194. Avid Bioservices Business Overview
Table 195. Avid Bioservices Small Molecule CMO and CDMO Product
Table 196. Avid Bioservices Revenue (2020-2025) & (US$ Million)
Table 197. Avid Bioservices Recent Development
Table 198. NextPharma Company Details
Table 199. NextPharma Business Overview
Table 200. NextPharma Small Molecule CMO and CDMO Product
Table 201. NextPharma Revenue (2020-2025) & (US$ Million)
Table 202. NextPharma Recent Development
Table 203. Alcami Company Details
Table 204. Alcami Business Overview
Table 205. Alcami Small Molecule CMO and CDMO Product
Table 206. Alcami Revenue (2020-2025) & (US$ Million)
Table 207. Alcami Recent Development
Table 208. Societal CDMO Company Details
Table 209. Societal CDMO Business Overview
Table 210. Societal CDMO Small Molecule CMO and CDMO Product
Table 211. Societal CDMO Revenue (2020-2025) & (US$ Million)
Table 212. Societal CDMO Recent Development
Table 213. MedPharm Company Details
Table 214. MedPharm Business Overview
Table 215. MedPharm Small Molecule CMO and CDMO Product
Table 216. MedPharm Revenue (2020-2025) & (US$ Million)
Table 217. MedPharm Recent Development
Table 218. Euroapi Company Details
Table 219. Euroapi Business Overview
Table 220. Euroapi Small Molecule CMO and CDMO Product
Table 221. Euroapi Revenue (2020-2025) & (US$ Million)
Table 222. Euroapi Recent Development
Table 223. BioVectra Company Details
Table 224. BioVectra Business Overview
Table 225. BioVectra Small Molecule CMO and CDMO Product
Table 226. BioVectra Revenue (2020-2025) & (US$ Million)
Table 227. BioVectra Recent Development
Table 228. Pfizer CentreOne Company Details
Table 229. Pfizer CentreOne Business Overview
Table 230. Pfizer CentreOne Small Molecule CMO and CDMO Product
Table 231. Pfizer CentreOne Revenue (2020-2025) & (US$ Million)
Table 232. Pfizer CentreOne Recent Development
Table 233. Fermion Company Details
Table 234. Fermion Business Overview
Table 235. Fermion Small Molecule CMO and CDMO Product
Table 236. Fermion Revenue (2020-2025) & (US$ Million)
Table 237. Fermion Recent Development
Table 238. Lundbeck Company Details
Table 239. Lundbeck Business Overview
Table 240. Lundbeck Small Molecule CMO and CDMO Product
Table 241. Lundbeck Revenue (2020-2025) & (US$ Million)
Table 242. Lundbeck Recent Development
Table 243. Research Programs/Design for This Report
Table 244. Key Data Information from Secondary Sources
Table 245. Key Data Information from Primary Sources
Figure 1. Global Small Molecule CMO and CDMO Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 2. Global Small Molecule CMO and CDMO Market Share by Type: 2024 VS 2031
Figure 3. Molecular Drug Intermediates Features
Figure 4. API Features
Figure 5. Prepared Products Features
Figure 6. Global Small Molecule CMO and CDMO Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Global Small Molecule CMO and CDMO Market Share by Application: 2024 VS 2031
Figure 8. Clinical Case Studies
Figure 9. Commercial Case Studies
Figure 10. Small Molecule CMO and CDMO Report Years Considered
Figure 11. Global Small Molecule CMO and CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Small Molecule CMO and CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Small Molecule CMO and CDMO Market Share by Region: 2024 VS 2031
Figure 14. Global Small Molecule CMO and CDMO Market Share by Players in 2024
Figure 15. Global Top Small Molecule CMO and CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule CMO and CDMO as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Small Molecule CMO and CDMO Revenue in 2024
Figure 17. North America Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Small Molecule CMO and CDMO Market Share by Type (2020-2031)
Figure 19. North America Small Molecule CMO and CDMO Market Share by Application (2020-2031)
Figure 20. North America Small Molecule CMO and CDMO Market Share by Country (2020-2031)
Figure 21. United States Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Small Molecule CMO and CDMO Market Share by Type (2020-2031)
Figure 25. Europe Small Molecule CMO and CDMO Market Share by Application (2020-2031)
Figure 26. Europe Small Molecule CMO and CDMO Market Share by Country (2020-2031)
Figure 27. Germany Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. China Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. China Small Molecule CMO and CDMO Market Share by Type (2020-2031)
Figure 35. China Small Molecule CMO and CDMO Market Share by Application (2020-2031)
Figure 36. Asia Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia Small Molecule CMO and CDMO Market Share by Type (2020-2031)
Figure 38. Asia Small Molecule CMO and CDMO Market Share by Application (2020-2031)
Figure 39. Asia Small Molecule CMO and CDMO Market Share by Region (2020-2031)
Figure 40. Japan Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. China Taiwan Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. India Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Australia Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Share by Type (2020-2031)
Figure 48. Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Share by Application (2020-2031)
Figure 49. Middle East, Africa, and Latin America Small Molecule CMO and CDMO Market Share by Country (2020-2031)
Figure 50. Brazil Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Mexico Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Turkey Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Israel Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. GCC Countries Small Molecule CMO and CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Catalent Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 58. Lonza Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 59. Siegfried Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 60. Recipharm Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 62. WuXi AppTech Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 63. WuXi Biologics Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 64. Fareva Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 65. Samsung Biologics Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 66. Aenova Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 67. Delpharm Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 68. Strides Pharma Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 69. Piramal Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 70. Famar Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 71. Curia Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 72. Jubilant Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 73. Vetter Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 74. AGC Pharma Chemicals Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 75. Asymchem Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 76. Porton Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 77. Eurofins Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 78. Ascendia Pharmaceuticals Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 79. Ardena Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 80. CPL Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 81. UPM Pharmaceuticals Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 82. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 83. Groupe Parima Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 84. TBD Pharmatech Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 85. Avid Bioservices Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 86. NextPharma Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 87. Alcami Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 88. Societal CDMO Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 89. MedPharm Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 90. Euroapi Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 91. BioVectra Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 92. Pfizer CentreOne Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 93. Fermion Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 94. Lundbeck Revenue Growth Rate in Small Molecule CMO and CDMO Business (2020-2025)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed